| Literature DB >> 21991403 |
Kimberly A Dodd1, Brian H Bird, Marina L Khristova, César G Albariño, Serena A Carroll, James A Comer, Bobbie R Erickson, Pierre E Rollin, Stuart T Nichol.
Abstract
BACKGROUND: Alkhurma hemorrhagic fever virus (AHFV) and Kyasanur forest disease virus (KFDV) cause significant human disease and mortality in Saudi Arabia and India, respectively. Despite their distinct geographic ranges, AHFV and KFDV share a remarkably high sequence identity. Given its emergence decades after KFDV, AHFV has since been considered a variant of KFDV and thought to have arisen from an introduction of KFDV to Saudi Arabia from India. To gain a better understanding of the evolutionary history of AHFV and KFDV, we analyzed the full length genomes of 16 AHFV and 3 KFDV isolates. METHODOLOGY/PRINCIPALEntities:
Mesh:
Substances:
Year: 2011 PMID: 21991403 PMCID: PMC3186760 DOI: 10.1371/journal.pntd.0001352
Source DB: PubMed Journal: PLoS Negl Trop Dis ISSN: 1935-2727
Figure 1Map of regions where AHFV or KFDV have been isolated.
AHFV cases have been documented in southern and western Saudi Arabia (Jizan/Najran and Jeddah/Makkah), and most recently at the Egypt-Sudan border (Bir Shalatyn or Shalatin). KFDV cases have been confined to Karnataka State, India (outlined).
AHFV and KFDV isolates included in analysis.
| Isolate | Year isolated | Location | Source | Length (nt) sequenced | GenBank Accession |
| KFDV-P9605 | 1957 | Karnataka | Human | 10774 | JF416958 |
| KFDV-G1138 | 1957 | Karnataka | Tick ( | 10694 | JF416959 |
| KFDV-W377 | 1957 | Karnataka |
| 10694 | JF416960 |
| AHFV-809006 | 1994 | Makkah | Human | 10775 | JF416957 |
| AHFV-807321 | 1995 | Makkah | Human | 10749 | JF416956 |
| AHFV-1176* | 1995 | Makkah | Human | 10685 | AF331718 |
| AHFV-200201032 | 2002 | Makkah | Human | 10749 | JF416949 |
| AHFV-200201034 | 2002 | Makkah | Human | 10749 | JF416950 |
| AHFV-200201035 | 2002 | Makkah | Human | 10749 | JF416951 |
| AHFV-200201036 | 2002 | Makkah | Human | 10749 | JF416952 |
| AHFV-200204519 | 2002 | Najran | Human | 10749 | JF416953 |
| AHFV-200300001 | 2002 | Makkah | Human | 10749 | JF416954 |
| AHFV-200307463 | 2003 | Jizan | Human | 10749 | JF416955 |
| AHFV-JE7* | 2004 | Jeddah | Tick ( | 7367 | DQ154114 |
| AHFV-200904529 | 2009 | Najran | Tick ( | 10749 | JF416961 |
| AHFV-200905915 | 2009 | Najran | Tick ( | 10749 | JF416963 |
| AHFV-200905916 | 2009 | Najran | Tick ( | 10749 | JF416964 |
| AHFV-200905919 | 2009 | Najran | Tick ( | 10749 | JF416965 |
| AHFV-200905921 | 2009 | Najran | Tick ( | 10749 | JF416966 |
| AHFV-200905922 | 2009 | Najran | Tick ( | 10749 | JF416967 |
| AHFV-200905926 | 2009 | Najran | Tick ( | 10749 | JF416962 |
AHFV JE-7 and AHFV 1176 sequences were taken from GenBank (Acc. # DQ154114.1 and AF331718, respectively). With those exceptions (AHFV JE-7 and AHFV 1176) all other sequences terminate at the viral 3′ terminus. Longer sequences of AHFV 809006 and KFDV P9605 are due to sequencing of the 3′ RACE products of the complement strand of viral RNA. Shorter sequences of KFDV G11338 and KFDV W-377 resulted from the use of a different 5′ forward primer (6F instead of 1F). SMB – suckling mouse brain; E6 – Vero E6 passage; M – mouse.
Primers used for amplification of AHFV and KFDV.
| Primer | Location | Sequence (5′ – 3′) |
| Alk1F | 27-46 |
|
| Alk6F | 81-100 |
|
| Alk5R | 3666-3648 |
|
| Alk2F | 3487-3505 |
|
| Alk2R | 7074-7055 |
|
| Alk7F | 6835-6852 |
|
| alkG1R | 10775-10755 |
|
| Oligo dT | N/A | Invitrogen 3′ RACE-AP |
| 3′RACE (v) | 9925-9943 |
|
| 3′RACE (vc) | 324-306 |
|
All primers successfully amplified KFDV and AHFV isolates (with the exceptions of AHFV JE-7 and AHFV 1176 that were derived from GenBank); however, efficient amplification of KFDV G11338 and KFDV W-377 required use of primer 6F, resulting in a slightly shorter final sequence.
Gene-specific genetic diversity.
| Gene | AHFV (dN/dS) | KFDV | AHFV v. KFDV | AHFV v. OHFV |
| C | 2.1 (0.33) | 0.0 | 6.9 | 30.1 |
| prM | 1.7 (0.24) | 0.0 | 8.6 | 32.2 |
| M | 2.7 (0.25) | 0.0 | 10.2 | 41.0 |
| E | 1.1 (0.11) | 0.3 | 8.3 | 29.1 |
| NS1 | 1.4 (0.14) | 0.3 | 8.9 | 30.8 |
| NS2a | 1.5 (0.17) | 0.3 | 8.7 | 37.7 |
| NS2b | 1.5 (0.10) | 0.0 | 6.2 | 29.4 |
| NS3 | 1.1 (0.11) | 0.2 | 7.1 | 27.7 |
| NS4a | 1.6 (0.11) | 0.0 | 8.7 | 36.6 |
| NS4b | 1.3 (0.24) | 0.1 | 7.4 | 32.1 |
| 2K | 2.9 (0.00) | 0.0 | 11.6 | 28.1 |
| NS5 | 1.0 (0.16) | 0.2 | 7.2 | 24.7 |
| Diversity (nt) | 1.1 | 0.2 | 8.4 | 29.4 |
| Diversity (aa) | 0.8 | 0.1 | 3.0 | 22.2 |
Maximum pairwise (nt) comparisons (listed as percentages) were made within AHFV sequences (2rd column), within KFDV sequences (3rd column), and between AHFV and KFDV sequences (4nd column). The 5th column shows maximum pairwise (nt) comparisons between AHFV and Omsk hemorrhagic fever virus (OHFV), another tick-borne hemorrhagic flavivirus (GenBank Acc. AY438626.1). The ratio of nonsynonymous to synonymous mutations (dN/dS) for AHFV are included in the 2nd column (in parentheses).
Figure 2AHFV and KFDV full-length genome phylogeny.
Phylogeny is based on Bayesian coalescent analysis of AHFV and KFDV full-length sequences. For selected clades, posterior probability values are listed above the TMRCA. Text color indicates host species: human isolates (green), tick pool isolates (blue), and nonhuman primate isolate (orange). The GenBank accession numbers are JF416949-67. Inset: Full-genome phylogeny with inclusion of short sequence fragments from 2010 Egyptian isolate (Shalatin, GenBank Acc. #HM629507, HM629508) shown in green.